
Manus Biosynthesis Inc Profile last edited on: 7/9/2018
CAGE: 6FXM9
UEI: V5C5JLKMRWU4
Business Identifier: Produce natural ingredients through fermentation Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
1030 Massachusetts Avenue Suite 300
Cambridge, MA 02139
Cambridge, MA 02139
(617) 299-8466 |
jwhaley@manusbio.com |
www.manusbio.com |
Location: Single
Congr. District: 07
County: Middlesex
Congr. District: 07
County: Middlesex
Public Profile
Plants produce a variety of rare natural products used as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. Manus Bio is structured to reduces dependence on land- and resource-intensive practices by recreating natural processes through biotechnology. Manus Biosynthesis applies the power of metabolic engineering, synthetic biology, and protein engineering to create de novo biocatalysts for synthesizing new chemical entities with applications in pharmaceuticals and consumer products. The firm utilizes a proprietary technology for engineering novel biochemistry in microorganisms for the sustainable manufacture of chemicals. Recent scientific advances in genome mining allow elucidation of complex chemistries and chemical reactions found in nature. At Manus Bio, the aim is to explore the untapped potential of natures biochemistry for human and societal applications.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
25-49Revenue Range
2.5M-5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2020 | 2 | NSF | $1,444,999 | |
Project Title: Development of a low-cost production platform through engineered bacteria for a novel natural acaricide | ||||
2018 | 1 | USDA | $98,980 | |
Project Title: Combined Fermentation-based Biosynthesis and Whole-Animal Screening Platform for Biobased Nematicide Discovery & Commercialization | ||||
2013 | 1 | NSF | $225,000 | |
Project Title: Overcoming Metabolic Pathway Limitations through De Novo Pathway Design for Terpenoid Biosynthesis | ||||
2012 | 1 | NSF | $150,000 | |
Project Title: Engineering Bacteria for Low Cost Renewable Biochemical Production | ||||
2012 | 1 | NSF | $180,000 | |
Project Title: Engineering Microbial Biosynthesis of a Non-caloric Natural Sweetener |
Key People / Management
Ajikumar Parayil -- Ceo & Founder
Carsten Boers -- Board Member
Ajikumar Parayil Kumaran -- CoFounder and CTO
Ryan Philippe -- DireCTOr R&D
Christopher Pirie -- CoFounder and Senior Scientist
Christine Santos
Jason Whaley -- Founder
Carsten Boers -- Board Member
Ajikumar Parayil Kumaran -- CoFounder and CTO
Ryan Philippe -- DireCTOr R&D
Christopher Pirie -- CoFounder and Senior Scientist
Christine Santos
Jason Whaley -- Founder
Company News
There are no news available.